1998
DOI: 10.1177/039139889802100910
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Thrombogenicity Testing of Artificial Organs

Abstract: Thromboembolic complications remain as one of the main problems for blood contacting artificial organs such as heart valves, bloodpumps and others. In vitro evaluation of thrombogenesis in prototypes has not previously been part of the standard evaluation of these devices. In comparison to hemolysis testing, evaluation of the thrombogenic potential is more difficult to perform because of the complexity of the blood coagulation system. We present an in vitro testing procedure that allows the accelerated examina… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0

Year Published

1999
1999
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 6 publications
0
20
0
Order By: Relevance
“…Historically, the development of blood recirculating devices has focused on hemolysis as an indicator of flow-induced blood trauma (25). More recent work (26) has shown that device thrombogenicity is largely driven by platelet activation.…”
Section: Discussionmentioning
confidence: 99%
“…Historically, the development of blood recirculating devices has focused on hemolysis as an indicator of flow-induced blood trauma (25). More recent work (26) has shown that device thrombogenicity is largely driven by platelet activation.…”
Section: Discussionmentioning
confidence: 99%
“…42 It was indicated that the functional relationship could be fine-tuned by readjusting the coefficients in the formula according to in vitro data. It was concluded that the coefficients in the trauma prediction equations were not universal, rather depending on the flow conditions and may be valid only for predominantly laminar flows.…”
Section: Discussionmentioning
confidence: 99%
“…1 The performance of these valves is evaluated in engineering terms, i.e., the noise level, 26 energy loss, 6,33 and regurgitation, 17 as well as biologically, i.e., hemolysis and the thrombogenicity of the valve itself. 9,23 These factors are linked mainly to the fluid dynamics near the valve. In contrast, relatively few studies have examined the hemodynamics downstream from the valve, despite the fact that if stagnation occurs in the ventricular cavity, the risk of thrombosis increases.…”
Section: Introductionmentioning
confidence: 99%